EconomyLens.com
No Result
View All Result
Tuesday, October 13, 2026
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
EconomyLens.com
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials
No Result
View All Result
EconomyLens.com
No Result
View All Result
Home Business

Bosses resign at Japan supplement firm probing deaths

Andrew Murphy by Andrew Murphy
July 22, 2024
in Business
Reading Time: 4 mins read
A A
4
32
SHARES
402
VIEWS
Share on FacebookShare on Twitter

Kobayashi Pharmaceutical Co. President Akihiro Kobayashi (2nd L) and others bow their heads at a press conference in Osaka in March as the firm faces a health scare linked to its over-the-counter tablets containing red yeast rice. ©AFP

Tokyo (AFP) – The chairman and president of a major Japanese dietary supplement maker announced their resignation on Tuesday, as the company probes 80 deaths potentially linked to tablets meant to lower cholesterol.

Related

Goldman Sachs profits jump as CEO says no plans to exit

French supermarkets suffer refrigerator shutdown after ‘unprecedented’ cyberattack

NZ bank in free speech row over ‘explicit’ sheep memes

Brazil prosecutors sue Shell for $108 mn over deadly 2024 floods

BMW pulls car lease offer from German far-right politician

Kobayashi Pharmaceutical is at the centre of a health scare linked to its over-the-counter tablets containing red yeast rice, which is fermented with a mould culture. Medical studies say red yeast rice or “beni koji” can improve cholesterol levels but also warn of a risk of organ damage depending on the ingredient’s chemical make-up.

A company statement said president Akihiro Kobayashi and chairman Kazumasa Kobayashi were leaving their posts. Both men belong to the firm’s founding family. The decision was made “to clarify executive responsibility over a series of actions by our company related to the ‘beni koji’ issue”, Kobayashi Pharmaceutical said.

Red yeast rice has been used in food, alcoholic drinks and folk medicine for centuries around East Asia. The scandal erupted in March when the company, a household name in Japan, recalled three brands of dietary supplements after customers complained of kidney problems. It later said it had detected a potentially toxic acid produced by the mould at one of its factories, and the government inspected the firm’s facilities. Last month, the company said it was probing a total of 80 deaths possibly connected to its pills, and investigating whether organs other than kidneys were harmed. But at the time the government called Kobayashi Pharmaceutical’s delay in reporting the number of cases under investigation “extremely regrettable”.

On Tuesday, the company’s board of directors said in a separate statement that they “pray for the souls of those who died…and offer condolences to the bereaved families”. The company’s new president is Satoshi Yamane, previously head of sustainability policy, the company said. Outgoing president Akihiro Kobayashi, who has expressed his intention to take responsibility for any harm caused, will remain in an executive role to manage compensation-related matters, it added.

Kobayashi’s red yeast rice supplements are regulated under a system created in 2015 under former premier Shinzo Abe. Some watchdogs have reportedly expressed concerns that the regulation of these products is not sufficiently stringent and that they do not always have the advertised effects.

© 2024 AFP

Tags: health scarepharmaceuticalsresignation
Share13Tweet8Share2Pin3Send
Previous Post

Theme park’s novel bid to fix South Korea youth unemployment

Next Post

Markets mixed after US rally ahead of inflation report

Andrew Murphy

Andrew Murphy

Related Posts

Business

Saint Laurent designer Vaccarello leaves after glittering decade

October 10, 2026
Business

US suspending Microsoft from visa program: Vance

October 8, 2026
Business

Britain’s Burnham says open to Germany joining warplane project

October 8, 2026
Business

French luxury giant to fund redevelopment of two Paris streets: city hall

October 7, 2026
Business

HSBC ‘consults’ over UK unit job cuts amid AI adoption

October 8, 2026
Business

Moldova to name new power line after Donald Trump

October 7, 2026
Next Post

Markets mixed after US rally ahead of inflation report

India on $24 bn jobs drive in Modi's first post-election budget

Stocks diverge tracking US election battle, earnings

EU opens probe into possible online food-delivery cartel

0 0 votes
Article Rating
Subscribe
Notify of
guest
guest
4 Comments
Oldest
Newest Most Voted
  • Trending
  • Comments
  • Latest

New York ruling deals Trump business a major blow

September 30, 2024

Elon Musk’s X fights Australian watchdog over church stabbing posts

April 21, 2024

Women journalists bear the brunt of cyberbullying

April 22, 2024

France probes TotalEnergies over 2021 Mozambique attack

May 6, 2024

New York ruling deals Trump business a major blow

104

Ghanaian finance ministry warns against fallout from anti-LGBTQ law

74

Shady bleaching jabs fuel health fears, scams in W. Africa

71

Stock markets waver, oil prices edge up

65

Apple unveils HomeView smart display in renewed home push

October 13, 2026

Goldman Sachs profits jump as CEO says no plans to exit

October 13, 2026

France budget debate faces rocky start as Socialists vow to fight

October 13, 2026

EU economy chief doubtful Russian diesel exports will affect prices

October 13, 2026
EconomyLens Logo

We bring the world economy to you. Get the latest news and insights on the global economy, from trade and finance to technology and innovation.

Your Privacy Choices

Pages

  • Home
  • About Us
  • Privacy Policy
  • Contact Us

Categories

  • Business
  • Economy
  • Markets
  • Tech
  • Editorials

Network

  • Coolinarco.com
  • CasualSelf.com
  • Fit.CasualSelf.com
  • Sport.CasualSelf.com
  • SportBeep.com
  • MachinaSphere.com
  • MagnifyPost.com
  • TodayAiNews.com
  • VideosArena.com
© 2026 EconomyLens.com - Top economic news from around the world.
No Result
View All Result
  • Home
  • Economy
  • Business
  • Markets
  • Tech
  • Editorials

© 2024 EconomyLens.com - Top economic news from around the world.